Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3-18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study). [PDF]
EClinicalMedicine, 2023 Cinza-Estévez Z +25 more
europepmc +1 more source
Science from medical care [PDF]
Academic training supports the bases for the graduate's research performance. However, on the path between the undergraduate projection and the postgraduate redesign of the study plans, difficulties persist in the research process.
Edel Garcia Vega +2 more
core +1 more source
The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases. [PDF]
J Neuroimmunol, 2021 Cama VF +19 more
europepmc +1 more source
Synthesis, LC-MS/MS analysis, and biological evaluation of two vaccine candidates against ticks based on the antigenic P0 peptide from R. sanguineus linked to the p64K carrier protein from Neisseria meningitidis. [PDF]
Anal Bioanal Chem, 2021 González LJ +22 more
europepmc +1 more source
Protein kinase CK2 - diverse roles in cancer cell biology and therapeutic promise. [PDF]
Mol Cell Biochem, 2023 Trembley JH +5 more
europepmc +1 more source
An overview on the treatments and prevention against COVID-19. [PDF]
Virol J, 2023 Panahi Y +6 more
europepmc +1 more source
Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody. [PDF]
Immunol Lett, 2022 Saavedra D +13 more
europepmc +1 more source
Neurological Adverse Reactions to SARS-CoV-2 Vaccines. [PDF]
Clin Psychopharmacol Neurosci, 2023 Finsterer J.
europepmc +1 more source